Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

March 2003

Volume 12, Issue 2

Pages 89–176

  1. Editorials

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Adverse drug reactions, MedWatch reporting and medical student education (pages 93–95)

      Lionel D. Lewis and David W. Nierenberg

      Version of Record online: 18 FEB 2003 | DOI: 10.1002/pds.801

  2. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Improving the quality of adverse drug reaction reporting by 4th-year medical students (pages 97–101)

      Curtis J. Rosebraugh, Yi Tsong, Feng Zhou, Min Chen, Ann Corken Mackey, Charlene Flowers, Denise Toyer, David A. Flockhart and Peter K. Honig

      Version of Record online: 3 JAN 2003 | DOI: 10.1002/pds.797

  3. Original Reports

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Descriptive analyses of the integrity of a US Medicaid claims database (pages 103–111)

      Sean Hennessy PharmD, Warren B. Bilker, Anita Weber and Brian L. Strom

      Version of Record online: 1 NOV 2002 | DOI: 10.1002/pds.765

  4. Original Papers

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Prescriptions of systemic antibiotics for children in Germany aged between 0 and 6 years (pages 113–120)

      Christoph Schindler, Jutta Krappweis, Ingolf Morgenstern and Wilhelm Kirch

      Version of Record online: 18 DEC 2002 | DOI: 10.1002/pds.786

  5. Original Reports

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy? (pages 121–127)

      José A. Spoelstra, Ronald P. Stolk, Eibert R. Heerdink, Olaf H. Klungel, Joëlle A. Erkens, Hubert G. M. Leufkens and Diederick E. Grobbee

      Version of Record online: 1 NOV 2002 | DOI: 10.1002/pds.760

  6. Research Articles

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. The use of anti-asthmatic medications among pediatric patients in Taiwan (pages 129–133)

      Chi-Yu Chen, Hui-Fen Chiu, Ming-Kung Yeh, Chih-Ching Chang and Chun-Yuh Yang

      Version of Record online: 20 JAN 2003 | DOI: 10.1002/pds.810

    2. Drug-induced renal function impairment: a population-based survey (pages 135–143)

      Taco B. M. Monster, Paul E. de Jong and Lolkje T. W. de Jong-van den Berg

      Version of Record online: 20 JAN 2003 | DOI: 10.1002/pds.811

  7. Keynote Addresses

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
  8. Letters to the Editor

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Defining dose decrease (pages 151–152)

      Robert J. Temple

      Version of Record online: 18 FEB 2003 | DOI: 10.1002/pds.812

  9. ISPE Commentaries

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. Bringing epidemiology into drug utilisation research (pages 153–156)

      Jacques LeLorier, Robert H. Vander Stichele, Jerry Avorn, Keith Beard, Jesper Hallas and David A. Henry

      Version of Record online: 18 FEB 2003 | DOI: 10.1002/pds.817

  10. Errata

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness
    1. You have free access to this content
  11. Current Awareness

    1. Top of page
    2. Editorials
    3. Research Articles
    4. Original Reports
    5. Original Papers
    6. Original Reports
    7. Research Articles
    8. Keynote Addresses
    9. Letters to the Editor
    10. ISPE Commentaries
    11. Errata
    12. Current Awareness

SEARCH

SEARCH BY CITATION